1. Home
  2. ASTC vs LEXX Comparison

ASTC vs LEXX Comparison

Compare ASTC & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrotech Corporation (DE)

ASTC

Astrotech Corporation (DE)

HOLD

Current Price

$3.50

Market Cap

10.5M

Sector

Industrials

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

SELL

Current Price

$4.03

Market Cap

9.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ASTC
LEXX
Founded
1984
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
9.5M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
ASTC
LEXX
Price
$3.50
$4.03
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.3K
★ 20.6K
Earning Date
11-13-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 2600.00
N/A
EPS
★ 0.25
N/A
Revenue
★ $1,000,000.00
$705,923.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6,915.00
P/E Ratio
$14.32
★ N/A
Revenue Growth
N/A
★ 52.05
52 Week Low
$1.92
$0.35
52 Week High
$68.85
$21.60

Technical Indicators

Market Signals
Indicator
ASTC
LEXX
Relative Strength Index (RSI) 26.15 54.77
Support Level $2.14 $2.67
Resistance Level $3.76 $4.79
Average True Range (ATR) 0.34 0.39
MACD -0.01 0.04
Stochastic Oscillator 7.01 56.88

Price Performance

Historical Comparison
ASTC
LEXX

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology company. It creates, operates and scales businesses through its subsidiaries and technology platforms, including space-related technology, instrumentation, mass spectrometry, gas chromatography, process-control and environmental analysis technologies. It is evaluating opportunities to identify, develop and commercialize technologies with potential applications in space, defense, industrial, environmental, quantum computing, AI, semiconductor materials, lunar infrastructure and related markets. Its products include Tracer 1000 ETD, tracer 1000 NTD, Labrador HHGC, Fenceline GC, AgLab 1000-D2, among others. It operates in single segment.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: